$715 million Bioelectronics Firm to be Created by GlaxoSmithKline and Alphabet

With the aim of creating a powerful new force in bioelectronics and use electrical signals rather than chemical or biological drugs to treat disease, GlaxoSmithKline has teamed up with Alphabet, Google’s holding company. With the ultimate aim of development of commercial bioelectronic medicines, Galvani Bioelectronics is being set up by GSK and Alphabet’s Verily Life Sciences —…

Stumbling Stocks Result in $51 Billion Loss for World’s Biggest Pension Fund

With losses exacerbated by unfavorable currency moves and a foray into equity markets, the world’s biggest pension fund posted the worst annual performance since the global financial crisis. The retirement manager said on Friday in Tokyo that 5.3 trillion yen ($51 billion) or 3.8 percent was lost by Japan’s $1.3 trillion Government Pension Investment Fund…